Human Health
QBECO Site Specific Immunomodulator for Treatment of Ulcerative Colitis
SOFi07- Project Leaders: Simon Sutcliffe, David Mullins, Hal Gunn
- Institutions: Qu Biologics Inc
- Budget: $957700
- Program/Competition: Strategic Opportunities Fund for Industry
- Genome Centre(s): Genome British Columbia
- Fiscal Year: 2015
- Status: Closed
